Regulatory Framework for Investigational New Drug (IND) in India
In India, the regulatory framework for investigational new drug (IND) is governed by the CDSCO under the DCGI. INDs are regulated by the New Drugs and Clinical Trials Rules, 2019 (with amendments in 2026). It ensures that investigational drugs undergo rigorous safety,...
Designing Pharma Manufacturing Facility: 10 Mistakes to Avoid
Planning and designing a pharma manufacturing facility means creating a controlled, compliant, and efficient environment. This environment ensures safe and high-quality medicines are consistently produced. It involves careful site selection, zoning of clean and...
CDSCO Enforces 30-Day Deadline for Drug Application Queries
CDSCO notice, dated May 4, 2026, stated that long-pending applications on the SUGAM portal awaiting query response will be rejected. It directs all applicants to respond to regulatory queries within 30 days of issuance. The notice highlights that numerous applications...